TY - JOUR AU - Lu, Christine Y. AU - Williams, Kenneth M. AU - Day, Richard O. PY - 2007 DA - 2007/03/01 TI - The funding and use of high-cost medicines in Australia: the example of anti-rheumatic biological medicines JO - Australia and New Zealand Health Policy SP - 2 VL - 4 IS - 1 AB - Subsidised access to high-cost medicines in Australia is restricted under national programs (the Pharmaceutical Benefits Scheme, PBS, and the Repatriation Pharmaceutical Benefits Scheme, RPBS) with a view to achieving cost-effective use. The aim of this study was to examine the use and associated government cost of biological agents for treating rheumatoid arthritis over the first two years of subsidy, and to compare these data to the predicted outcomes. SN - 1743-8462 UR - https://doi.org/10.1186/1743-8462-4-2 DO - 10.1186/1743-8462-4-2 ID - Lu2007 ER -